top of page
TELESCOPE
NEOADJUVANT PHASE II STUDY OF PEMBROLIZUMAB AND CARBOPLATIN PLUS PACLITAXEL FOR STAGE I TRIPLE-NEGATIVE BREAST CANCER (THE TELESCOPE STUDY).
Breast Cancer
II
30
Pending
Spain
Set-up
CLINICAL TRIAL DETAILS
THE STUDY WILL EVALUATE AN ANTHRACYCLINE-FREE REGIMEN FOR PATIENTS WITH T1CN0 TRIPLE-NEGATIVE BREAST CANCER. THE PRIMARY OBJECTIVE IS TO EVALUATE THE PATHOLOGICAL COMPLETE RESPONSE RATE DEFINED AS THE PERCENTAGE OF PATIENTS WITH YPT0/IS, YPN0 AT SURGERY BASED ON LOCAL ASSESSMENT.
TELESCOPE AT CLINICALTRIALS.GOV
TUMOR TYPE
PHASE
N
SITES
COUNTRY
STATUS
TRIAL RESUME
bottom of page